Longitudinal monitoring of EGFR mutation and amplification status in circulating epithelial tumor cells (CETC) of lung cancer patients
Background:EAC from BE is increasing and the prognosis is poor. The
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Background:EAC from BE is increasing and the prognosis is poor. The
Colorectal cancer (CRC) is the third most common cancer diagnosed in the
Wang Yongxiang, Gao Liang and Shao Qinshu PDF Share this article
Similarly higher frequency of this mutation was reported in adenocarcinoma (76.08%) than squamous cell carcinoma 27 (50%) (p<0.0134). Significantly higher frequency of R282W p53 mutation was reported in distant
could restore in part the functional activity of mutated LXR-α gene found in peripheral blood mononuclear cells of CHD patients. Our data also indicated that CHD patients contain significant
Mutations of selenoprotein N (SEPN1) cause a congenital myopathy, SEPN1-related myopathy (SEPN1-RM), characterized by severe weakness and wasting of neck and trunk muscles, scoliosis and lethal respiratory failure…
analyze gastric signet ring cell (SRC) carcinoma subtypes by investigating gastric and intestinal phenotypic marker expression, and explore the relationship between phenotype and K-ras mutation. Immunohistochemistry was…
Esophageal squamous cell carcinoma (ESCC) is the eighth most common and the sixth most lethal cancer worldwide. However, although genomic studies have identified some mutations associated with ESCC, we know
malignant behavior. Recent molecular studies have characterized the FOXL2 402C>G mutation in adult-type granulosa cell tumor. In this study, we report an 80-year-old woman with ... gene revealed defective DNA mismatch…
aspects and long-term outcomes of pediatric T-ALL and T-cell lymphoblastic lymphoma (T-LBL) with USP7 mutations. Methods: 313 pediatric patients with T-ALL/T-LBL were enrolled
which is already known to cause CAIS. We focused on the effect of this mutation on the testicular histopathology of the patient. Surface spreading of testicular tissues showed an absence ... This meiotic failure is…
reactive T cells and disruption leads to fatal autoimmunity in mice. Using whole exome and targeted sequencing approaches we have identified a number of individuals with heterozygous mutations in CTLA ... site and…
activating mutations as an early predictor of disease progression before clinical or radiological evidence. For this observational study, 35 patients with advanced, EGFR-positive, nonsquamous, non-small cell lung cancer…
recent years, limited reports of epidermal growth factor receptor mutations in pulmonary large cell neuroendocrine tumors have implicated potential therapeutic targets in a tumor which has historically been treated with…
constructed hepatocellular carcinoma (HCC) cells that stably express stathmin with a Ser25 phosphorylation site mutation (stathmin S25A). We used the polymerase chain reaction for site-directed mutagenesis, constructed…
Although oncological treatment of pancreatic adenocarcinoma (PDAC) has improved within the last
completely changed. Not too long ago, we still considered “carcinoma compatible with non small cell lung cancer” as a valid histopathologic diagnosis, good enough to start a patient on chemotherapy ... accurate…
Melanoma may be a harmful skin tumor with a tall metastatic movement
Genetic alterations related to carcinogenesis, including punctual mutations, may have a potential
most common genetic mechanisms contributing to telomerase activation in malignant cells. Mutation of the TERT promoter appears to be an indicator of worse outcome and is correlated with tumor aggressiveness ... date the…
through their effect on growth plate chondrocytes. However, the effect of FGFR3 mutations on bone progenitor cells may differ. The objective of this study was to investigate the effect ... PDCs were isolated from…
effect of epidermal growth factor receptor gene (EGFR) mutation on bevacizumab combined with erlotinib in the treatment of non-small cell lung cancer. Methods: Fifty-nine patients with non-small ... with erlotinib is…
For authors and organisers
Find the right journal for your paper and submit your manuscript.